Mostrar el registro sencillo del ítem
The effectiveness of ICT-based neurocognitive and psychosocial rehabilitation programmes in people with mild dementia and mild cognitive impairment using GRADIOR and ehcoBUTLER: study protocol for a randomised controlled trial
dc.contributor.author | Vanova, Martina | |
dc.contributor.author | Irazoki, Eider | |
dc.contributor.author | García-Casal, J. Antonio | |
dc.contributor.author | Martínez-Abad, Fernando | |
dc.contributor.author | Botella, Cristina | |
dc.contributor.author | Shiells, Kate R. | |
dc.contributor.author | Franco-Martín, Manuel A. | |
dc.date.accessioned | 2018-05-18T14:53:55Z | |
dc.date.available | 2018-05-18T14:53:55Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | VANOVA, Martina, et al. The effectiveness of ICT-based neurocognitive and psychosocial rehabilitation programmes in people with mild dementia and mild cognitive impairment using GRADIOR and ehcoBUTLER: study protocol for a randomised controlled trial. Trials, 2018, vol. 19, núm. 1, p.100 | ca_CA |
dc.identifier.issn | 1745-6215 | |
dc.identifier.uri | http://hdl.handle.net/10234/174755 | |
dc.description.abstract | Background: Cognitive rehabilitation is a highly individualised, non-pharmacological intervention for people with mild cognitive impairment (MCI) and dementia, which in recent years has also been developed for various IT platforms. Methods: In this study, we aim to evaluate the effectiveness of the cognitive rehabilitation software GRADIOR in a multi-centre, single-blinded randomised controlled trial with people with MCI and mild dementia. A total of 400 people with MCI and mild dementia will be randomly allocated to one of four groups. This trial will compare the cognitive rehabilitation treatment using the GRADIOR programme with a psychosocial stimulation intervention (PSS) using the ehcoBUTLER platform, with a combined treatment consisting of GRADIOR and ehcoBUTLER, and with a group receiving treatment as usual during a period of 1 year. Discussion: The outcomes of this clinical trial will be to determine any relevant changes in cognition, mood, quality of life, activities of daily living and quality of patient-carer relationship after 4 months and 1 year of intervention in a cross-sectional group comparison. Participants will be followed-up for 1 year to investigate potential long-term effects of the conducted treatments. Trial registration: Current Controlled Trials ISRCTN, ID: 15742788. Registered on 12 June 2017 | ca_CA |
dc.format.extent | 15 p. | ca_CA |
dc.format.mimetype | application/pdf | ca_CA |
dc.language.iso | eng | ca_CA |
dc.publisher | BioMed Central | ca_CA |
dc.relation.isPartOf | Trials, 2018, vol. 19, núm. 1, p.100 | ca_CA |
dc.rights | © The Author(s). 2018 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | ca_CA |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-sa/4.0/ | * |
dc.subject | Dementia | ca_CA |
dc.subject | Alzheimer ’ s disease | ca_CA |
dc.subject | MCI | ca_CA |
dc.subject | cognitive rehabilitation | ca_CA |
dc.subject | cognitive intervention | ca_CA |
dc.subject | Computer-based intervention | ca_CA |
dc.subject | psychosocial intervention | ca_CA |
dc.subject | cognition | ca_CA |
dc.title | The effectiveness of ICT-based neurocognitive and psychosocial rehabilitation programmes in people with mild dementia and mild cognitive impairment using GRADIOR and ehcoBUTLER: study protocol for a randomised controlled trial | ca_CA |
dc.type | info:eu-repo/semantics/article | ca_CA |
dc.identifier.doi | https://doi.org/10.1186/s13063-017-2371-z | |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca_CA |
dc.relation.publisherVersion | https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-2371-z | ca_CA |
dc.type.version | info:eu-repo/semantics/publishedVersion | ca_CA |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
PSB_Articles [1330]
Articles de publicacions periòdiques
Excepto si se señala otra cosa, la licencia del ítem se describe como: © The Author(s). 2018
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.